2
Announcements
Trials
Browse
Landscape
Status
Completed
506
Terminated
123
Recruiting
120
Unknown
88
Active not recruiting
49
Withdrawn
47
Not yet recruiting
18
Suspended
2
No longer available
1
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Neoplasms
14
Carcinoma, Non-Small-Cell Lung
8
Sarcoma
6
Prostatic Neoplasms
6
Pancreatic Neoplasms
6
Neuroblastoma
6
Multiple Myeloma
6
Recurrence
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Melanoma
5
Ovarian Neoplasms
4
Leukemia, Myeloid, Acute
4
Glioblastoma
4
Breast Neoplasms
4
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Urinary Bladder Neoplasms
2
Primary Myelofibrosis
2
Pheochromocytoma
2
Osteosarcoma
2
Non-Muscle Invasive Bladder Neoplasms
2
Neuroectodermal Tumors, Primitive
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Non-Hodgkin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Available
×
Burkitt Lymphoma
×
Clear all
NCT06799221
2026-02-27
Expanded Access Program for OOS Obe-cel
Autolus Limited
Available